Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Orenti

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The International Journal of Biological Markers|January 30, 2014
Performance of robust regression methods in real-time polymerase chain reaction calibrationAnnalisa Orenti, Ettore Marubini
ERJ Open Research|January 15, 2025
Variability in disease severity among cystic fibrosis patients carrying residual-function variants: data from the European Cystic Fibrosis Society Patient RegistryMeir Mei-Zahav, Annalisa Orenti, Andreas Jung, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 23, 2022
Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosisEitan Kerem, Annalisa Orenti, Anna Zolin, et al.
ERJ Open Research|September 3, 2025
Methicillin-resistant <i>Staphylococcus aureus</i> and pulmonary outcome in people with cystic fibrosis: a European Cystic Fibrosis Patient Registry data analysisMeir Mei-Zahav, Miri Dotan, Luigi Annicchiarico, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 4, 2023
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPAJacob D Bradbury, Emily Chesshyre, Annalisa Orenti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 31, 2022
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection - A European cystic fibrosis patient registry data analysisAnnalisa Orenti, Meir Mei-Zahav, Patrizia Boracchi, et al.
Scientific Reports|May 9, 2026
Use of robust regression methods to detect outliers and estimate parameters for Length-Weight relationships in fishesAnnalisa Orenti, Francis C Neat, Anna Zolin, et al.
Japanese Journal of Clinical Oncology|February 24, 2018
Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patientsDanila Coradini, Annalisa Orenti, Elisabetta Venturelli, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 30, 2021
Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational studyAnna Brivio, Annalisa Orenti, Mauro Barbisan, et al.
Respiratory Medicine|October 31, 2025
Changes in use of inhaled chronic antibiotics in the European CF population: an ECFS patient registry studyMarianne S Muhlebach, Lutz Naehrlich, Siobhán B Carr, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The International Journal of Biological Markers|January 30, 2014
Performance of robust regression methods in real-time polymerase chain reaction calibrationAnnalisa Orenti, Ettore Marubini
ERJ Open Research|January 15, 2025
Variability in disease severity among cystic fibrosis patients carrying residual-function variants: data from the European Cystic Fibrosis Society Patient RegistryMeir Mei-Zahav, Annalisa Orenti, Andreas Jung, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 23, 2022
Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosisEitan Kerem, Annalisa Orenti, Anna Zolin, et al.
ERJ Open Research|September 3, 2025
Methicillin-resistant <i>Staphylococcus aureus</i> and pulmonary outcome in people with cystic fibrosis: a European Cystic Fibrosis Patient Registry data analysisMeir Mei-Zahav, Miri Dotan, Luigi Annicchiarico, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 4, 2023
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPAJacob D Bradbury, Emily Chesshyre, Annalisa Orenti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 31, 2022
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection - A European cystic fibrosis patient registry data analysisAnnalisa Orenti, Meir Mei-Zahav, Patrizia Boracchi, et al.
Scientific Reports|May 9, 2026
Use of robust regression methods to detect outliers and estimate parameters for Length-Weight relationships in fishesAnnalisa Orenti, Francis C Neat, Anna Zolin, et al.
Japanese Journal of Clinical Oncology|February 24, 2018
Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patientsDanila Coradini, Annalisa Orenti, Elisabetta Venturelli, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 30, 2021
Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational studyAnna Brivio, Annalisa Orenti, Mauro Barbisan, et al.
Respiratory Medicine|October 31, 2025
Changes in use of inhaled chronic antibiotics in the European CF population: an ECFS patient registry studyMarianne S Muhlebach, Lutz Naehrlich, Siobhán B Carr, et al.
Pageof 6